Understanding how FGF21 affects bone health in Duchenne Muscular Dystrophy
Official title: Investigating the role of FGF21 in bone homeostasis in Duchenne Muscular Dystrophy
Funded at University of Iowa · NIH-11161782 · Data updated 2026-11-12
This study is looking at how a protein called FGF21 might help keep bones healthy for people with Duchenne Muscular Dystrophy (DMD), which can cause muscle loss and bone problems, and it aims to find new ways to prevent bone loss in these patients.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project start | May 1, 2025 |
| Project end | April 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $45,574 |
| NIH project number | 1F30HD118663-01 |
| Project ID | NIH-11161782 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Duchenne Muscular Dystrophy who are experiencing or at risk for osteoporosis.
✕Less likely to help
Patients without Duchenne Muscular Dystrophy or those who do not have bone health issues may not benefit from this research.
What this research studies
This research investigates the role of a protein called FGF21 in maintaining bone health for patients with Duchenne Muscular Dystrophy (DMD), a condition that leads to muscle loss and often results in severe bone issues. The study will use mouse models to explore how FGF21 influences the cells responsible for bone breakdown, known as osteoclasts, and how it may contribute to osteoporosis in DMD. By understanding the mechanisms behind FGF21's effects, researchers hope to identify potential treatments to prevent bone loss in affected patients.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that help prevent bone loss and fractures in patients with Duchenne Muscular Dystrophy.
How similar studies have gone: While the specific role of FGF21 in DMD is being explored, similar research has shown promise in understanding bone health in other conditions, suggesting potential for success in this novel approach.
Where this research is happening
-
University of Iowa
Iowa City, United States Active
Researchers
- Principal investigator: Hurley-Novatny, Amelia Charlotte — University of Iowa
- Study coordinator: Hurley-Novatny, Amelia Charlotte
Related research
Other NIH-funded projects on the same topics.
-
Advancing manufacturing and release testing for a Duchenne gene editing therapy
A project to optimize how a dual-vector AAV gene editing treatment for Duchenne muscular dystrophy is made and tested, so it can move toward clinical use.
-
Understanding why Duchenne Muscular Dystrophy worsens and how to stop it
A research team at USC is studying Duchenne muscular dystrophy to find out why the disease continues to progress and how to interrupt harmful changes in muscle tissue.
-
Stopping steroid-related muscle and bone wasting in Duchenne muscular dystrophy
Researchers are testing ways to protect muscles and bones in people with Duchenne muscular dystrophy who take long-term steroid medicines.
-
MR clues to how nNOS affects energy use and blood flow in Becker and Duchenne muscular dystrophy
This project looks at how advanced MRI tests can track muscle energy and blood flow changes in people with Becker and Duchenne muscular dystrophy as new gene therapies are explored.
-
Digital motor-skill tracking for infants with Duchenne Muscular Dystrophy using wearables
A wearable-sensor project aims to quietly track and quantify how motor skills develop in babies and young boys with Duchenne Muscular Dystrophy.
-
Genetic factors that influence Duchenne Muscular Dystrophy progression
A study to find genes that change how severe Duchenne muscular dystrophy is in boys and young men, using patient data and DNA samples.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.